$1,318.00
Approved drugs in the ADHF – preserved ejection fraction (acute HFpEF) space target natriuretic peptide receptors. These drugs are administered via the intravenous route.
This Market Spotlight report covers the Acute Decompensated Heart Failure (ADHF) market, comprising key marketed and pipeline drugs, upcoming events, licensing and asset acquisition deals, clinical trials, probability of success, and epidemiology information.
Key Takeaways
CONTENTS
5 OVERVIEW
6 KEY TAKEAWAYS
7 DISEASE BACKGROUND
7 Definition
7 Symptoms
7 Patient subtypes
7 Risk factors
7 Diagnosis
9 TREATMENT
9 Diuretics
9 Vasodilator therapy
10 Ultrafiltration (UF)
10 Inotropes
10 Natriuretic peptides
10 Vasopressors/Beta blockers/ACE inhibitors
11 Circulatory assist devices
11 Other therapies
12 EPIDEMIOLOGY
12 ADHF incidence
13 MARKETED DRUGS
13 Acute HFpEF
15 Acute HFrEF
17 PIPELINE DRUGS
17 Acute HFrEF
21 KEY UPCOMING EVENTS
21 Acute HFrEF
22 PROBABILITY OF SUCCESS
23 LICENSING AND ASSET ACQUISITION DEALS
23 Abiomed Buys Precardia
24 CLINICAL TRIAL LANDSCAPE
25 Sponsors by status
26 Sponsors by phase
27 Recent events
29 BIBLIOGRAPHY
30 APPENDIX
LIST OF FIGURES
17 Figure 1: Overview of pipeline drugs for acute HFrEF in the US
17 Figure 2: Pipeline drugs for acute HFrEF by, company
18 Figure 3: Pipeline drugs for acute HFrEF by, drug type
18 Figure 4: Pipeline drugs for acute HFrEF by, classification
21 Figure 5: Key upcoming events in acute HFrEF
22 Figure 6: Probability of success in the ADHF pipeline
24 Figure 7: Clinical trials in ADHF
24 Figure 8: Top 10 drugs for clinical trials in ADHF
25 Figure 9: Top 10 companies for clinical trials in ADHF
26 Figure 10: ADHF trials status
27 Figure 11: ADHF trials sponsors, by phase
LIST OF TABLES
14 Table 1: Marketed drugs for acute HFpEF
16 Table 2: Marketed drugs for acute HFrEF
19 Table 3: Pipeline drugs for acute HFrEF in the US
© Informa UK Ltd. This document is a licensed product and is not to be reproduced or redistributed
Do you have a subscription to Datamonitor Healthcare, Biomedtracker or Meddevicetracker? You may already have access to these reports, contact your account manager or email pharma@informabi.com for further help or assistance.
Sign up to the Pharma Intelligence Report Store Newsletter to get the latest blogs, news, reports and discounts!